CHARIFSON Paul,CLARK Michael P.,BANDARAGE Upul K.,BETHIEL Randy S.,COURT John J.,DENG Hongbo,DRUTU Ioana,DUFFY John P.,FARMER Luc,GAO Huai,GU Wenxin,JACOBS Dylan H.,KENNEDY Joseph M.,LEDEBOER Mark W.,DR
申请号：
SI201031779
公开号：
SI3141252T1
申请日:
2010.06.17
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( IA ) are as described herein. A compound is represented by Structural Formula ( IA ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( IA ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
